Related Experiment Video
Updated: Jan 3, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development and Testing of a Clinical Practice Framework for Pharmacists to Assess Patients' Travel-Related Risks:
Heidi V J Fernandes1, Sherilyn K D Houle1
1School of Pharmacy, University of Waterloo; Waterloo, ON N2L 3G1, Canada.
A new clinical practice framework, "The 5W Approach," helps pharmacists identify travel medicine risks. This tool aids inexperienced pharmacists in assessing patients, distinguishing those needing referral from those manageable within pharmacy practice.
Area of Science:
- Pharmacy Practice
- Travel Medicine
- Clinical Decision Support
Background:
- Pharmacists play a crucial role in public health, including travel medicine.
- A need exists for structured tools to guide pharmacists in assessing travel-related health risks.
- Existing tools may not be tailored to the specific scope of practice for community pharmacists.
Purpose of the Study:
- To develop and validate a clinical practice framework for pharmacists to identify patients requiring travel medicine management.
- To differentiate between patients manageable by pharmacists and those needing referral to specialists.
- To enhance pharmacist confidence and involvement in travel medicine services.
Main Methods:
- Expert panel (physicians, pharmacists with travel health certification) developed the framework through electronic consensus.
- Framework items were validated using the Item and Average Content Validity Index.
- Piloted in eight Ontario pharmacies with self-identified beginner pharmacists using pre- and post-test surveys.
Main Results:
- The validated framework, "The 5W Approach to Travel Risk Identification," comprises 64 essential items across 5 domains (Who, What, Where, When, Why).
- Achieved an Average-Content Validity Index of 0.91, indicating high expert agreement.
- Pharmacists found the tool simple, structured, and useful for patient interactions, though potentially less beneficial for highly experienced practitioners.
Conclusions:
- "The 5W Approach" provides a validated tool for pharmacists to assess travel medicine risks and patient disposition (referral or management).
- It empowers pharmacists with less travel medicine experience to utilize professional judgment effectively.
- Future research will focus on the feasibility of this framework in Canadian community pharmacy settings.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Dosing: Geriatric Patients
Clinical Trials
There are four phases in a clinical trial. A phase one...

